UniProt ID | ENOA_HUMAN | |
---|---|---|
UniProt AC | P06733 | |
Protein Name | Alpha-enolase | |
Gene Name | ENO1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 434 | |
Subcellular Localization |
Cytoplasm . Cell membrane . Cytoplasm, myofibril, sarcomere, M line . Can translocate to the plasma membrane in either the homodimeric (alpha/alpha) or heterodimeric (alpha/gamma) form. ENO1 is localized to the M line. Isoform MBP-1: Nucleus. |
|
Protein Description | Multifunctional enzyme that, as well as its role in glycolysis, plays a part in various processes such as growth control, hypoxia tolerance and allergic responses. May also function in the intravascular and pericellular fibrinolytic system due to its ability to serve as a receptor and activator of plasminogen on the cell surface of several cell-types such as leukocytes and neurons. Stimulates immunoglobulin production.; MBP1 binds to the myc promoter and acts as a transcriptional repressor. May be a tumor suppressor.. | |
Protein Sequence | MSILKIHAREIFDSRGNPTVEVDLFTSKGLFRAAVPSGASTGIYEALELRDNDKTRYMGKGVSKAVEHINKTIAPALVSKKLNVTEQEKIDKLMIEMDGTENKSKFGANAILGVSLAVCKAGAVEKGVPLYRHIADLAGNSEVILPVPAFNVINGGSHAGNKLAMQEFMILPVGAANFREAMRIGAEVYHNLKNVIKEKYGKDATNVGDEGGFAPNILENKEGLELLKTAIGKAGYTDKVVIGMDVAASEFFRSGKYDLDFKSPDDPSRYISPDQLADLYKSFIKDYPVVSIEDPFDQDDWGAWQKFTASAGIQVVGDDLTVTNPKRIAKAVNEKSCNCLLLKVNQIGSVTESLQACKLAQANGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLLRIEEELGSKAKFAGRNFRNPLAK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSILKIHAR ------CCCEEEEEH | 36.31 | 25944712 | |
2 | Phosphorylation | ------MSILKIHAR ------CCCEEEEEH | 36.31 | 24719451 | |
5 | 2-Hydroxyisobutyrylation | ---MSILKIHAREIF ---CCCEEEEEHHHH | 30.67 | - | |
5 | Acetylation | ---MSILKIHAREIF ---CCCEEEEEHHHH | 30.67 | 19608861 | |
5 | Malonylation | ---MSILKIHAREIF ---CCCEEEEEHHHH | 30.67 | 26320211 | |
5 | Succinylation | ---MSILKIHAREIF ---CCCEEEEEHHHH | 30.67 | 23954790 | |
5 | Ubiquitination | ---MSILKIHAREIF ---CCCEEEEEHHHH | 30.67 | 21890473 | |
5 | Ubiquitination | ---MSILKIHAREIF ---CCCEEEEEHHHH | 30.67 | 21890473 | |
5 | Ubiquitination | ---MSILKIHAREIF ---CCCEEEEEHHHH | 30.67 | 21890473 | |
9 | Methylation | SILKIHAREIFDSRG CCEEEEEHHHHHCCC | 24.31 | - | |
10 (in isoform 2) | Ubiquitination | - | 49.11 | - | |
14 | Phosphorylation | HAREIFDSRGNPTVE EEHHHHHCCCCCEEE | 31.19 | 21815630 | |
15 | Methylation | AREIFDSRGNPTVEV EHHHHHCCCCCEEEE | 51.24 | - | |
19 | Phosphorylation | FDSRGNPTVEVDLFT HHCCCCCEEEEEEEC | 33.04 | 30624053 | |
26 | Phosphorylation | TVEVDLFTSKGLFRA EEEEEEECCCCCHHE | 36.50 | 30266825 | |
27 | Phosphorylation | VEVDLFTSKGLFRAA EEEEEECCCCCHHEE | 19.86 | 30266825 | |
27 (in isoform 2) | Ubiquitination | - | 19.86 | 21890473 | |
28 | Acetylation | EVDLFTSKGLFRAAV EEEEECCCCCHHEEC | 57.48 | 23954790 | |
28 | Ubiquitination | EVDLFTSKGLFRAAV EEEEECCCCCHHEEC | 57.48 | 21890473 | |
28 (in isoform 1) | Ubiquitination | - | 57.48 | 21890473 | |
28 | Ubiquitination | EVDLFTSKGLFRAAV EEEEECCCCCHHEEC | 57.48 | 21890473 | |
28 | Ubiquitination | EVDLFTSKGLFRAAV EEEEECCCCCHHEEC | 57.48 | 21890473 | |
33 | Acetylation | TSKGLFRAAVPSGAS CCCCCHHEECCCCCC | 12.89 | 19608861 | |
33 | Ubiquitination | TSKGLFRAAVPSGAS CCCCCHHEECCCCCC | 12.89 | 19608861 | |
33 (in isoform 2) | Ubiquitination | - | 12.89 | 21890473 | |
37 | Phosphorylation | LFRAAVPSGASTGIY CHHEECCCCCCCCHH | 40.15 | 21945579 | |
40 | Phosphorylation | AAVPSGASTGIYEAL EECCCCCCCCHHHHH | 30.60 | 29255136 | |
41 | Phosphorylation | AVPSGASTGIYEALE ECCCCCCCCHHHHHH | 27.37 | 21945579 | |
44 | Phosphorylation | SGASTGIYEALELRD CCCCCCHHHHHHCCC | 9.11 | 29255136 | |
50 | Methylation | IYEALELRDNDKTRY HHHHHHCCCCCCCCC | 31.17 | - | |
54 | Acetylation | LELRDNDKTRYMGKG HHCCCCCCCCCCCCC | 40.95 | 23236377 | |
54 | Ubiquitination | LELRDNDKTRYMGKG HHCCCCCCCCCCCCC | 40.95 | 21890473 | |
54 (in isoform 1) | Ubiquitination | - | 40.95 | 21890473 | |
54 | Ubiquitination | LELRDNDKTRYMGKG HHCCCCCCCCCCCCC | 40.95 | 21890473 | |
54 | Ubiquitination | LELRDNDKTRYMGKG HHCCCCCCCCCCCCC | 40.95 | 21890473 | |
55 | Phosphorylation | ELRDNDKTRYMGKGV HCCCCCCCCCCCCCH | 29.87 | 28857561 | |
57 | Phosphorylation | RDNDKTRYMGKGVSK CCCCCCCCCCCCHHH | 18.56 | 22817900 | |
60 | 2-Hydroxyisobutyrylation | DKTRYMGKGVSKAVE CCCCCCCCCHHHHHH | 39.34 | - | |
60 | Acetylation | DKTRYMGKGVSKAVE CCCCCCCCCHHHHHH | 39.34 | 19608861 | |
60 | Succinylation | DKTRYMGKGVSKAVE CCCCCCCCCHHHHHH | 39.34 | - | |
60 | Succinylation | DKTRYMGKGVSKAVE CCCCCCCCCHHHHHH | 39.34 | 23954790 | |
60 | Ubiquitination | DKTRYMGKGVSKAVE CCCCCCCCCHHHHHH | 39.34 | 19608861 | |
60 (in isoform 1) | Ubiquitination | - | 39.34 | 21890473 | |
63 | Phosphorylation | RYMGKGVSKAVEHIN CCCCCCHHHHHHHHH | 24.46 | 28857561 | |
64 | Acetylation | YMGKGVSKAVEHINK CCCCCHHHHHHHHHH | 54.79 | 19608861 | |
64 | Ubiquitination | YMGKGVSKAVEHINK CCCCCHHHHHHHHHH | 54.79 | 19608861 | |
64 (in isoform 1) | Ubiquitination | - | 54.79 | 21890473 | |
64 | Ubiquitination | YMGKGVSKAVEHINK CCCCCHHHHHHHHHH | 54.79 | 21890473 | |
64 | Ubiquitination | YMGKGVSKAVEHINK CCCCCHHHHHHHHHH | 54.79 | 21890473 | |
71 | 2-Hydroxyisobutyrylation | KAVEHINKTIAPALV HHHHHHHHCHHHHHH | 40.48 | - | |
71 | Acetylation | KAVEHINKTIAPALV HHHHHHHHCHHHHHH | 40.48 | 19608861 | |
71 | Malonylation | KAVEHINKTIAPALV HHHHHHHHCHHHHHH | 40.48 | 26320211 | |
71 | Ubiquitination | KAVEHINKTIAPALV HHHHHHHHCHHHHHH | 40.48 | 21890473 | |
71 (in isoform 1) | Ubiquitination | - | 40.48 | 21890473 | |
71 | Ubiquitination | KAVEHINKTIAPALV HHHHHHHHCHHHHHH | 40.48 | 21890473 | |
71 | Ubiquitination | KAVEHINKTIAPALV HHHHHHHHCHHHHHH | 40.48 | 21890473 | |
72 | Phosphorylation | AVEHINKTIAPALVS HHHHHHHCHHHHHHH | 20.20 | 22617229 | |
79 | Phosphorylation | TIAPALVSKKLNVTE CHHHHHHHHCCCCCC | 25.56 | 23401153 | |
80 | 2-Hydroxyisobutyrylation | IAPALVSKKLNVTEQ HHHHHHHHCCCCCCH | 54.52 | - | |
80 | Acetylation | IAPALVSKKLNVTEQ HHHHHHHHCCCCCCH | 54.52 | 23954790 | |
80 | Malonylation | IAPALVSKKLNVTEQ HHHHHHHHCCCCCCH | 54.52 | 26320211 | |
80 | Ubiquitination | IAPALVSKKLNVTEQ HHHHHHHHCCCCCCH | 54.52 | 21906983 | |
80 (in isoform 1) | Ubiquitination | - | 54.52 | 21890473 | |
80 | Ubiquitination | IAPALVSKKLNVTEQ HHHHHHHHCCCCCCH | 54.52 | 21890473 | |
80 | Ubiquitination | IAPALVSKKLNVTEQ HHHHHHHHCCCCCCH | 54.52 | 21890473 | |
81 | 2-Hydroxyisobutyrylation | APALVSKKLNVTEQE HHHHHHHCCCCCCHH | 37.47 | - | |
81 | Acetylation | APALVSKKLNVTEQE HHHHHHHCCCCCCHH | 37.47 | 20433201 | |
81 | Malonylation | APALVSKKLNVTEQE HHHHHHHCCCCCCHH | 37.47 | 26320211 | |
81 | Ubiquitination | APALVSKKLNVTEQE HHHHHHHCCCCCCHH | 37.47 | - | |
81 (in isoform 1) | Ubiquitination | - | 37.47 | 21890473 | |
85 | Phosphorylation | VSKKLNVTEQEKIDK HHHCCCCCCHHHHHH | 30.77 | 26437602 | |
89 | Acetylation | LNVTEQEKIDKLMIE CCCCCHHHHHHHEEE | 56.77 | 19608861 | |
89 | Succinylation | LNVTEQEKIDKLMIE CCCCCHHHHHHHEEE | 56.77 | - | |
89 | Succinylation | LNVTEQEKIDKLMIE CCCCCHHHHHHHEEE | 56.77 | 27452117 | |
89 | Ubiquitination | LNVTEQEKIDKLMIE CCCCCHHHHHHHEEE | 56.77 | 19608861 | |
89 (in isoform 1) | Ubiquitination | - | 56.77 | 21890473 | |
92 | Acetylation | TEQEKIDKLMIEMDG CCHHHHHHHEEECCC | 43.35 | 23954790 | |
92 | Ubiquitination | TEQEKIDKLMIEMDG CCHHHHHHHEEECCC | 43.35 | 21906983 | |
92 (in isoform 1) | Ubiquitination | - | 43.35 | 21890473 | |
94 | Sulfoxidation | QEKIDKLMIEMDGTE HHHHHHHEEECCCCC | 2.76 | 21406390 | |
97 | Sulfoxidation | IDKLMIEMDGTENKS HHHHEEECCCCCCCH | 3.89 | 28465586 | |
100 | Acetylation | LMIEMDGTENKSKFG HEEECCCCCCCHHHC | 31.92 | 19608861 | |
100 | Phosphorylation | LMIEMDGTENKSKFG HEEECCCCCCCHHHC | 31.92 | 20068231 | |
100 | Ubiquitination | LMIEMDGTENKSKFG HEEECCCCCCCHHHC | 31.92 | 19608861 | |
100 (in isoform 2) | Ubiquitination | - | 31.92 | 21890473 | |
103 | 2-Hydroxyisobutyrylation | EMDGTENKSKFGANA ECCCCCCCHHHCHHH | 49.11 | - | |
103 | Acetylation | EMDGTENKSKFGANA ECCCCCCCHHHCHHH | 49.11 | 20433201 | |
103 | Ubiquitination | EMDGTENKSKFGANA ECCCCCCCHHHCHHH | 49.11 | 21906983 | |
103 (in isoform 1) | Ubiquitination | - | 49.11 | 21890473 | |
104 | Phosphorylation | MDGTENKSKFGANAI CCCCCCCHHHCHHHH | 44.81 | 28857561 | |
105 | Acetylation | DGTENKSKFGANAIL CCCCCCHHHCHHHHH | 49.80 | 20433201 | |
105 | Ubiquitination | DGTENKSKFGANAIL CCCCCCHHHCHHHHH | 49.80 | - | |
106 | Acetylation | GTENKSKFGANAILG CCCCCHHHCHHHHHH | 16.82 | 19608861 | |
109 (in isoform 2) | Ubiquitination | - | 28.08 | 21890473 | |
115 | Phosphorylation | ANAILGVSLAVCKAG HHHHHHHHHHHHHHC | 14.60 | - | |
119 | S-palmitoylation | LGVSLAVCKAGAVEK HHHHHHHHHHCHHHC | 1.76 | 29575903 | |
120 | Ubiquitination | GVSLAVCKAGAVEKG HHHHHHHHHCHHHCC | 43.17 | 21906983 | |
120 (in isoform 1) | Ubiquitination | - | 43.17 | 21890473 | |
126 | Acetylation | CKAGAVEKGVPLYRH HHHCHHHCCCCCHHH | 59.62 | 19608861 | |
126 | Malonylation | CKAGAVEKGVPLYRH HHHCHHHCCCCCHHH | 59.62 | 26320211 | |
126 | Ubiquitination | CKAGAVEKGVPLYRH HHHCHHHCCCCCHHH | 59.62 | 21890473 | |
126 (in isoform 1) | Ubiquitination | - | 59.62 | 21890473 | |
128 | Acetylation | AGAVEKGVPLYRHIA HCHHHCCCCCHHHHH | 4.35 | 19608861 | |
128 | Ubiquitination | AGAVEKGVPLYRHIA HCHHHCCCCCHHHHH | 4.35 | 19608861 | |
128 (in isoform 2) | Ubiquitination | - | 4.35 | 21890473 | |
131 | Phosphorylation | VEKGVPLYRHIADLA HHCCCCCHHHHHHHC | 8.28 | 26356563 | |
135 | Acetylation | VPLYRHIADLAGNSE CCCHHHHHHHCCCCE | 10.31 | 19608861 | |
135 | Ubiquitination | VPLYRHIADLAGNSE CCCHHHHHHHCCCCE | 10.31 | 19608861 | |
135 (in isoform 2) | Ubiquitination | - | 10.31 | 21890473 | |
140 | Acetylation | HIADLAGNSEVILPV HHHHHCCCCEEEEEE | 29.41 | 19608861 | |
140 | Ubiquitination | HIADLAGNSEVILPV HHHHHCCCCEEEEEE | 29.41 | 19608861 | |
140 (in isoform 2) | Ubiquitination | - | 29.41 | 21890473 | |
141 | Phosphorylation | IADLAGNSEVILPVP HHHHCCCCEEEEEEC | 32.11 | 28450419 | |
157 | Phosphorylation | FNVINGGSHAGNKLA EEEECCCCCCCCHHH | 16.15 | 28450419 | |
163 | Acetylation | GSHAGNKLAMQEFMI CCCCCCHHHHCEECE | 5.79 | 19608861 | |
163 | Ubiquitination | GSHAGNKLAMQEFMI CCCCCCHHHHCEECE | 5.79 | 19608861 | |
163 (in isoform 2) | Ubiquitination | - | 5.79 | 21890473 | |
165 | Sulfoxidation | HAGNKLAMQEFMILP CCCCHHHHCEECEEC | 5.94 | 21406390 | |
169 | Sulfoxidation | KLAMQEFMILPVGAA HHHHCEECEECCCHH | 2.79 | 30846556 | |
169 (in isoform 2) | Ubiquitination | - | 2.79 | 21890473 | |
183 | Methylation | ANFREAMRIGAEVYH HHHHHHHHHCHHHHH | 31.10 | - | |
188 | Acetylation | AMRIGAEVYHNLKNV HHHHCHHHHHHHHHH | 6.13 | 19608861 | |
188 | Ubiquitination | AMRIGAEVYHNLKNV HHHHCHHHHHHHHHH | 6.13 | 19608861 | |
188 (in isoform 2) | Ubiquitination | - | 6.13 | 21890473 | |
189 | Phosphorylation | MRIGAEVYHNLKNVI HHHCHHHHHHHHHHH | 4.05 | 21712546 | |
192 | Acetylation | GAEVYHNLKNVIKEK CHHHHHHHHHHHHHH | 2.45 | 19608861 | |
192 | Ubiquitination | GAEVYHNLKNVIKEK CHHHHHHHHHHHHHH | 2.45 | 19608861 | |
192 (in isoform 2) | Ubiquitination | - | 2.45 | 21890473 | |
193 | 2-Hydroxyisobutyrylation | AEVYHNLKNVIKEKY HHHHHHHHHHHHHHH | 55.26 | - | |
193 | Acetylation | AEVYHNLKNVIKEKY HHHHHHHHHHHHHHH | 55.26 | 19608861 | |
193 | Malonylation | AEVYHNLKNVIKEKY HHHHHHHHHHHHHHH | 55.26 | 26320211 | |
193 | Ubiquitination | AEVYHNLKNVIKEKY HHHHHHHHHHHHHHH | 55.26 | 21890473 | |
193 (in isoform 1) | Ubiquitination | - | 55.26 | 21890473 | |
193 | Ubiquitination | AEVYHNLKNVIKEKY HHHHHHHHHHHHHHH | 55.26 | 21890473 | |
193 | Ubiquitination | AEVYHNLKNVIKEKY HHHHHHHHHHHHHHH | 55.26 | 21890473 | |
197 | Acetylation | HNLKNVIKEKYGKDA HHHHHHHHHHHCCCC | 43.82 | 26051181 | |
197 | Ubiquitination | HNLKNVIKEKYGKDA HHHHHHHHHHHCCCC | 43.82 | 22053931 | |
199 | Acetylation | LKNVIKEKYGKDATN HHHHHHHHHCCCCCC | 55.06 | 19608861 | |
199 | Ubiquitination | LKNVIKEKYGKDATN HHHHHHHHHCCCCCC | 55.06 | 19608861 | |
200 | Phosphorylation | KNVIKEKYGKDATNV HHHHHHHHCCCCCCC | 30.42 | 28152594 | |
202 | Acetylation | VIKEKYGKDATNVGD HHHHHHCCCCCCCCC | 40.89 | 23954790 | |
202 | Malonylation | VIKEKYGKDATNVGD HHHHHHCCCCCCCCC | 40.89 | 26320211 | |
202 | Sumoylation | VIKEKYGKDATNVGD HHHHHHCCCCCCCCC | 40.89 | 28112733 | |
202 | Ubiquitination | VIKEKYGKDATNVGD HHHHHHCCCCCCCCC | 40.89 | - | |
202 (in isoform 1) | Ubiquitination | - | 40.89 | 21890473 | |
205 | Phosphorylation | EKYGKDATNVGDEGG HHHCCCCCCCCCCCC | 40.34 | 28152594 | |
221 | 2-Hydroxyisobutyrylation | APNILENKEGLELLK CCCHHCCHHHHHHHH | 43.73 | - | |
221 | Acetylation | APNILENKEGLELLK CCCHHCCHHHHHHHH | 43.73 | 23954790 | |
221 | Succinylation | APNILENKEGLELLK CCCHHCCHHHHHHHH | 43.73 | 23954790 | |
221 | Sumoylation | APNILENKEGLELLK CCCHHCCHHHHHHHH | 43.73 | 19608861 | |
221 | Ubiquitination | APNILENKEGLELLK CCCHHCCHHHHHHHH | 43.73 | 21890473 | |
221 (in isoform 1) | Ubiquitination | - | 43.73 | 21890473 | |
221 | Ubiquitination | APNILENKEGLELLK CCCHHCCHHHHHHHH | 43.73 | 21890473 | |
221 | Ubiquitination | APNILENKEGLELLK CCCHHCCHHHHHHHH | 43.73 | 21890473 | |
228 | 2-Hydroxyisobutyrylation | KEGLELLKTAIGKAG HHHHHHHHHHHHHCC | 48.84 | - | |
228 | Acetylation | KEGLELLKTAIGKAG HHHHHHHHHHHHHCC | 48.84 | 19608861 | |
228 | Other | KEGLELLKTAIGKAG HHHHHHHHHHHHHCC | 48.84 | 29775581 | |
228 | Succinylation | KEGLELLKTAIGKAG HHHHHHHHHHHHHCC | 48.84 | - | |
228 | Succinylation | KEGLELLKTAIGKAG HHHHHHHHHHHHHCC | 48.84 | 23954790 | |
228 | Ubiquitination | KEGLELLKTAIGKAG HHHHHHHHHHHHHCC | 48.84 | 19608861 | |
228 (in isoform 1) | Ubiquitination | - | 48.84 | 21890473 | |
229 | Phosphorylation | EGLELLKTAIGKAGY HHHHHHHHHHHHCCC | 24.39 | 28857561 | |
233 | N6-malonyllysine | LLKTAIGKAGYTDKV HHHHHHHHCCCCCEE | 32.31 | - | |
233 | 2-Hydroxyisobutyrylation | LLKTAIGKAGYTDKV HHHHHHHHCCCCCEE | 32.31 | - | |
233 | Acetylation | LLKTAIGKAGYTDKV HHHHHHHHCCCCCEE | 32.31 | 19608861 | |
233 | Malonylation | LLKTAIGKAGYTDKV HHHHHHHHCCCCCEE | 32.31 | 26320211 | |
233 | Ubiquitination | LLKTAIGKAGYTDKV HHHHHHHHCCCCCEE | 32.31 | 21890473 | |
233 (in isoform 1) | Ubiquitination | - | 32.31 | 21890473 | |
233 (in isoform 2) | Ubiquitination | - | 32.31 | 21890473 | |
233 | Ubiquitination | LLKTAIGKAGYTDKV HHHHHHHHCCCCCEE | 32.31 | 21890473 | |
233 | Ubiquitination | LLKTAIGKAGYTDKV HHHHHHHHCCCCCEE | 32.31 | 21890473 | |
236 | Nitration | TAIGKAGYTDKVVIG HHHHHCCCCCEEEEC | 19.34 | - | |
236 | Phosphorylation | TAIGKAGYTDKVVIG HHHHHCCCCCEEEEC | 19.34 | 19835603 | |
237 | Phosphorylation | AIGKAGYTDKVVIGM HHHHCCCCCEEEECE | 28.55 | 19835603 | |
239 | 2-Hydroxyisobutyrylation | GKAGYTDKVVIGMDV HHCCCCCEEEECEEH | 30.51 | - | |
239 | Acetylation | GKAGYTDKVVIGMDV HHCCCCCEEEECEEH | 30.51 | 20433201 | |
239 | Ubiquitination | GKAGYTDKVVIGMDV HHCCCCCEEEECEEH | 30.51 | - | |
242 (in isoform 2) | Ubiquitination | - | 4.18 | 21890473 | |
244 | Sulfoxidation | TDKVVIGMDVAASEF CCEEEECEEHHHHHH | 2.29 | 21406390 | |
249 | Phosphorylation | IGMDVAASEFFRSGK ECEEHHHHHHHHCCC | 25.79 | 29514088 | |
250 | Acetylation | GMDVAASEFFRSGKY CEEHHHHHHHHCCCC | 44.04 | 19608861 | |
250 | Ubiquitination | GMDVAASEFFRSGKY CEEHHHHHHHHCCCC | 44.04 | 19608861 | |
250 (in isoform 2) | Ubiquitination | - | 44.04 | 21890473 | |
254 | Phosphorylation | AASEFFRSGKYDLDF HHHHHHHCCCCCCCC | 34.18 | 23401153 | |
256 | 2-Hydroxyisobutyrylation | SEFFRSGKYDLDFKS HHHHHCCCCCCCCCC | 36.52 | - | |
256 | Acetylation | SEFFRSGKYDLDFKS HHHHHCCCCCCCCCC | 36.52 | 19608861 | |
256 | Malonylation | SEFFRSGKYDLDFKS HHHHHCCCCCCCCCC | 36.52 | 26320211 | |
256 | Methylation | SEFFRSGKYDLDFKS HHHHHCCCCCCCCCC | 36.52 | 19608861 | |
256 | Sumoylation | SEFFRSGKYDLDFKS HHHHHCCCCCCCCCC | 36.52 | 19608861 | |
256 | Ubiquitination | SEFFRSGKYDLDFKS HHHHHCCCCCCCCCC | 36.52 | 21890473 | |
256 (in isoform 1) | Ubiquitination | - | 36.52 | 21890473 | |
256 | Ubiquitination | SEFFRSGKYDLDFKS HHHHHCCCCCCCCCC | 36.52 | 21890473 | |
256 | Ubiquitination | SEFFRSGKYDLDFKS HHHHHCCCCCCCCCC | 36.52 | 21890473 | |
257 | Phosphorylation | EFFRSGKYDLDFKSP HHHHCCCCCCCCCCC | 25.84 | 30266825 | |
262 | 2-Hydroxyisobutyrylation | GKYDLDFKSPDDPSR CCCCCCCCCCCCHHH | 61.82 | - | |
262 | Acetylation | GKYDLDFKSPDDPSR CCCCCCCCCCCCHHH | 61.82 | 20433201 | |
262 | Succinylation | GKYDLDFKSPDDPSR CCCCCCCCCCCCHHH | 61.82 | 23954790 | |
262 | Sumoylation | GKYDLDFKSPDDPSR CCCCCCCCCCCCHHH | 61.82 | - | |
262 | Ubiquitination | GKYDLDFKSPDDPSR CCCCCCCCCCCCHHH | 61.82 | 21890473 | |
262 (in isoform 1) | Ubiquitination | - | 61.82 | 21890473 | |
262 | Ubiquitination | GKYDLDFKSPDDPSR CCCCCCCCCCCCHHH | 61.82 | 21890473 | |
262 | Ubiquitination | GKYDLDFKSPDDPSR CCCCCCCCCCCCHHH | 61.82 | 21890473 | |
263 | Phosphorylation | KYDLDFKSPDDPSRY CCCCCCCCCCCHHHC | 33.29 | 22167270 | |
268 | Phosphorylation | FKSPDDPSRYISPDQ CCCCCCHHHCCCHHH | 44.72 | 21945579 | |
270 | Phosphorylation | SPDDPSRYISPDQLA CCCCHHHCCCHHHHH | 15.30 | 21945579 | |
272 | Phosphorylation | DDPSRYISPDQLADL CCHHHCCCHHHHHHH | 17.31 | 23927012 | |
280 | Phosphorylation | PDQLADLYKSFIKDY HHHHHHHHHHHHCCC | 12.72 | 21945579 | |
281 | 2-Hydroxyisobutyrylation | DQLADLYKSFIKDYP HHHHHHHHHHHCCCC | 46.30 | - | |
281 | Acetylation | DQLADLYKSFIKDYP HHHHHHHHHHHCCCC | 46.30 | 19608861 | |
281 | Other | DQLADLYKSFIKDYP HHHHHHHHHHHCCCC | 46.30 | 29775581 | |
281 | Succinylation | DQLADLYKSFIKDYP HHHHHHHHHHHCCCC | 46.30 | 23954790 | |
281 | Ubiquitination | DQLADLYKSFIKDYP HHHHHHHHHHHCCCC | 46.30 | 21890473 | |
281 (in isoform 1) | Ubiquitination | - | 46.30 | 21890473 | |
281 | Ubiquitination | DQLADLYKSFIKDYP HHHHHHHHHHHCCCC | 46.30 | 21890473 | |
281 | Ubiquitination | DQLADLYKSFIKDYP HHHHHHHHHHHCCCC | 46.30 | 21890473 | |
282 | Phosphorylation | QLADLYKSFIKDYPV HHHHHHHHHHCCCCE | 20.74 | 22617229 | |
285 | Acetylation | DLYKSFIKDYPVVSI HHHHHHHCCCCEEEE | 49.55 | 19608861 | |
285 | Methylation | DLYKSFIKDYPVVSI HHHHHHHCCCCEEEE | 49.55 | 19608861 | |
285 | Succinylation | DLYKSFIKDYPVVSI HHHHHHHCCCCEEEE | 49.55 | 23954790 | |
285 | Ubiquitination | DLYKSFIKDYPVVSI HHHHHHHCCCCEEEE | 49.55 | 19608861 | |
285 (in isoform 1) | Ubiquitination | - | 49.55 | 21890473 | |
287 | Phosphorylation | YKSFIKDYPVVSIED HHHHHCCCCEEEECC | 7.91 | 22115753 | |
291 | Phosphorylation | IKDYPVVSIEDPFDQ HCCCCEEEECCCCCC | 22.09 | 26356563 | |
306 | Acetylation | DDWGAWQKFTASAGI CCCCHHHHHHHCCCC | 33.70 | 70179 | |
308 | O-linked_Glycosylation | WGAWQKFTASAGIQV CCHHHHHHHCCCCEE | 27.09 | OGP | |
308 | Phosphorylation | WGAWQKFTASAGIQV CCHHHHHHHCCCCEE | 27.09 | 27050516 | |
310 | Phosphorylation | AWQKFTASAGIQVVG HHHHHHHCCCCEEEC | 24.78 | 25159151 | |
313 | Acetylation | KFTASAGIQVVGDDL HHHHCCCCEEECCCC | 2.55 | 19608861 | |
313 | Ubiquitination | KFTASAGIQVVGDDL HHHHCCCCEEECCCC | 2.55 | 19608861 | |
313 (in isoform 2) | Ubiquitination | - | 2.55 | 21890473 | |
321 | Phosphorylation | QVVGDDLTVTNPKRI EEECCCCEECCHHHH | 32.07 | 27251275 | |
323 | Phosphorylation | VGDDLTVTNPKRIAK ECCCCEECCHHHHHH | 40.34 | 27251275 | |
326 | 2-Hydroxyisobutyrylation | DLTVTNPKRIAKAVN CCEECCHHHHHHHCC | 59.51 | - | |
326 | Acetylation | DLTVTNPKRIAKAVN CCEECCHHHHHHHCC | 59.51 | 26051181 | |
326 | Ubiquitination | DLTVTNPKRIAKAVN CCEECCHHHHHHHCC | 59.51 | 21906983 | |
326 (in isoform 1) | Ubiquitination | - | 59.51 | 21890473 | |
327 | Acetylation | LTVTNPKRIAKAVNE CEECCHHHHHHHCCC | 35.04 | 19608861 | |
327 | Ubiquitination | LTVTNPKRIAKAVNE CEECCHHHHHHHCCC | 35.04 | 19608861 | |
327 (in isoform 2) | Ubiquitination | - | 35.04 | 21890473 | |
330 | 2-Hydroxyisobutyrylation | TNPKRIAKAVNEKSC CCHHHHHHHCCCCCC | 50.96 | - | |
330 | Acetylation | TNPKRIAKAVNEKSC CCHHHHHHHCCCCCC | 50.96 | 20433201 | |
330 | Succinylation | TNPKRIAKAVNEKSC CCHHHHHHHCCCCCC | 50.96 | 23954790 | |
330 | Ubiquitination | TNPKRIAKAVNEKSC CCHHHHHHHCCCCCC | 50.96 | - | |
335 | Acetylation | IAKAVNEKSCNCLLL HHHHCCCCCCCEEEE | 55.92 | 23954790 | |
335 | Phosphoglycerylation | IAKAVNEKSCNCLLL HHHHCCCCCCCEEEE | 55.92 | - | |
335 | Ubiquitination | IAKAVNEKSCNCLLL HHHHCCCCCCCEEEE | 55.92 | 21890473 | |
335 (in isoform 1) | Ubiquitination | - | 55.92 | 21890473 | |
335 | Ubiquitination | IAKAVNEKSCNCLLL HHHHCCCCCCCEEEE | 55.92 | 21890473 | |
335 | Ubiquitination | IAKAVNEKSCNCLLL HHHHCCCCCCCEEEE | 55.92 | 21890473 | |
336 | Phosphorylation | AKAVNEKSCNCLLLK HHHCCCCCCCEEEEE | 12.37 | 24114839 | |
337 | S-nitrosylation | KAVNEKSCNCLLLKV HHCCCCCCCEEEEEH | 6.54 | 2212679 | |
337 | S-palmitoylation | KAVNEKSCNCLLLKV HHCCCCCCCEEEEEH | 6.54 | 29575903 | |
339 | S-palmitoylation | VNEKSCNCLLLKVNQ CCCCCCCEEEEEHHH | 3.12 | 29575903 | |
343 | 2-Hydroxyisobutyrylation | SCNCLLLKVNQIGSV CCCEEEEEHHHHCCH | 38.82 | - | |
343 | Acetylation | SCNCLLLKVNQIGSV CCCEEEEEHHHHCCH | 38.82 | 23954790 | |
343 | Phosphoglycerylation | SCNCLLLKVNQIGSV CCCEEEEEHHHHCCH | 38.82 | - | |
343 | Ubiquitination | SCNCLLLKVNQIGSV CCCEEEEEHHHHCCH | 38.82 | 21890473 | |
343 (in isoform 1) | Ubiquitination | - | 38.82 | 21890473 | |
343 | Ubiquitination | SCNCLLLKVNQIGSV CCCEEEEEHHHHCCH | 38.82 | 21890473 | |
343 | Ubiquitination | SCNCLLLKVNQIGSV CCCEEEEEHHHHCCH | 38.82 | 21890473 | |
349 | Phosphorylation | LKVNQIGSVTESLQA EEHHHHCCHHHHHHH | 27.74 | 20068231 | |
351 | Phosphorylation | VNQIGSVTESLQACK HHHHCCHHHHHHHHH | 22.89 | 20068231 | |
353 | Phosphorylation | QIGSVTESLQACKLA HHCCHHHHHHHHHHH | 19.20 | 20068231 | |
357 | S-palmitoylation | VTESLQACKLAQANG HHHHHHHHHHHHHCC | 2.09 | 29575903 | |
358 | Acetylation | TESLQACKLAQANGW HHHHHHHHHHHHCCC | 50.28 | 23954790 | |
358 | Succinylation | TESLQACKLAQANGW HHHHHHHHHHHHCCC | 50.28 | 23954790 | |
358 | Ubiquitination | TESLQACKLAQANGW HHHHHHHHHHHHCCC | 50.28 | - | |
368 | Sulfoxidation | QANGWGVMVSHRSGE HHCCCEEEEECCCCC | 1.95 | 30846556 | |
370 | Phosphorylation | NGWGVMVSHRSGETE CCCEEEEECCCCCCC | 8.62 | - | |
372 | Methylation | WGVMVSHRSGETEDT CEEEEECCCCCCCCC | 38.56 | - | |
373 | Phosphorylation | GVMVSHRSGETEDTF EEEEECCCCCCCCCH | 35.24 | 30278072 | |
376 | Phosphorylation | VSHRSGETEDTFIAD EECCCCCCCCCHHHH | 42.56 | 30278072 | |
379 | Phosphorylation | RSGETEDTFIADLVV CCCCCCCCHHHHHHH | 15.65 | 30278072 | |
389 | S-palmitoylation | ADLVVGLCTGQIKTG HHHHHHHHCCCCCCC | 3.10 | 26865113 | |
390 | Phosphorylation | DLVVGLCTGQIKTGA HHHHHHHCCCCCCCC | 36.84 | 28060719 | |
394 | Ubiquitination | GLCTGQIKTGAPCRS HHHCCCCCCCCCCCH | 32.78 | - | |
395 | Phosphorylation | LCTGQIKTGAPCRSE HHCCCCCCCCCCCHH | 39.96 | 23882029 | |
406 | 2-Hydroxyisobutyrylation | CRSERLAKYNQLLRI CCHHHHHHHHHHHHH | 49.69 | - | |
406 | Acetylation | CRSERLAKYNQLLRI CCHHHHHHHHHHHHH | 49.69 | 25825284 | |
406 | Ubiquitination | CRSERLAKYNQLLRI CCHHHHHHHHHHHHH | 49.69 | 21890473 | |
406 (in isoform 1) | Ubiquitination | - | 49.69 | 21890473 | |
406 | Ubiquitination | CRSERLAKYNQLLRI CCHHHHHHHHHHHHH | 49.69 | 21890473 | |
406 | Ubiquitination | CRSERLAKYNQLLRI CCHHHHHHHHHHHHH | 49.69 | 21890473 | |
412 | Methylation | AKYNQLLRIEEELGS HHHHHHHHHHHHHHH | 42.75 | - | |
419 | Phosphorylation | RIEEELGSKAKFAGR HHHHHHHHHHHHCCC | 41.90 | 23401153 | |
420 | N6-malonyllysine | IEEELGSKAKFAGRN HHHHHHHHHHHCCCC | 54.52 | - | |
420 | 2-Hydroxyisobutyrylation | IEEELGSKAKFAGRN HHHHHHHHHHHCCCC | 54.52 | - | |
420 | Acetylation | IEEELGSKAKFAGRN HHHHHHHHHHHCCCC | 54.52 | 19608861 | |
420 | Malonylation | IEEELGSKAKFAGRN HHHHHHHHHHHCCCC | 54.52 | 26320211 | |
420 | Succinylation | IEEELGSKAKFAGRN HHHHHHHHHHHCCCC | 54.52 | - | |
420 | Ubiquitination | IEEELGSKAKFAGRN HHHHHHHHHHHCCCC | 54.52 | 19608861 | |
420 (in isoform 1) | Ubiquitination | - | 54.52 | 21890473 | |
422 | Acetylation | EELGSKAKFAGRNFR HHHHHHHHHCCCCCC | 39.21 | 72614587 | |
422 | Ubiquitination | EELGSKAKFAGRNFR HHHHHHHHHCCCCCC | 39.21 | - | |
434 | Acetylation | NFRNPLAK------- CCCCCCCC------- | 69.43 | 11923871 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ENOA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ENOA_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-5; LYS-60; LYS-64; LYS-71;LYS-89; LYS-126; LYS-193; LYS-199; LYS-228; LYS-233; LYS-256; LYS-281;LYS-285; LYS-406 AND LYS-420, AND MASS SPECTROMETRY. | |
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-71, AND MASS SPECTROMETRY. | |
Malonylation | |
Reference | PubMed |
"The first identification of lysine malonylation substrates and itsregulatory enzyme."; Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,Dai J., Verdin E., Ye Y., Zhao Y.; Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011). Cited for: MALONYLATION AT LYS-233 AND LYS-420. | |
N6-malonyllysine | |
Reference | PubMed |
"The first identification of lysine malonylation substrates and itsregulatory enzyme."; Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,Dai J., Verdin E., Ye Y., Zhao Y.; Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011). Cited for: MALONYLATION AT LYS-233 AND LYS-420. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; TYR-44; SER-272 ANDTHR-390, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-254 AND SER-263, ANDMASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-57 AND SER-63, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-72, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-44 AND TYR-287, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-44 AND TYR-287, AND MASSSPECTROMETRY. |